tiprankstipranks
Trending News
More News >
Nolato AB Class B (NLTBF)
OTHER OTC:NLTBF
US Market

Nolato AB (NLTBF) Earnings Dates, Call Summary & Reports

Compare
3 Followers

Earnings Data

Report Date
May 06, 2026
Before Open (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.08
Last Year’s EPS
0.08
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed a broadly positive strategic and financial picture for the full year—sales growth, a double-digit increase in operating profit for the year, improved margins, higher EPS, a larger dividend, strong cash generation, improved ROCE and notable sustainability achievements. Near-term Q4-specific headwinds (currency effects, start-up costs, year-end volume weakness and volatile precious metal prices) weighed on quarterly results and will partially carry into Q1 2026, but management characterized these as temporary and actionable (pricing adjustments, ongoing ramp-ups, and planned expansions). Overall, the highlights (annual profitability and margin improvement, medical growth, sustainability milestones and financial strength enabling M&A) outweigh the temporary lowlights.
Company Guidance
Management guided that Q4 sales were just shy of SEK 2.3bn (net sales SEK 2,272m) with ~2% currency-adjusted growth but a 7% FX headwind, EBITA of SEK 236m (vs SEK 240m) and an EBITA margin of 10.4% for the quarter (FY margin 11.3% vs 9.9% in 2024, +1.4pp), noting full‑year 2025 sales close to SEK 9.5bn, EPS SEK 2.88, a proposed dividend of SEK 1.70 (payout 59% vs 61%), and a strong balance sheet enabling M&A; Medical Solutions (58% of group) delivered just above SEK 1.3bn (+5% adj.) with an 11.6% margin (+0.4pp) while Engineered (42% of group) was close to SEK 1bn with materials up ~10% adj. but a 100bp negative hit (largely from silver pricing and customer shutdowns); temporary headwinds (US start‑up costs ~‑0.5pp on medical, lower year‑end volumes, higher precious metal costs) reduced Q4 by ~SEK 25–30m vs Q3 and will partly carry into Q1, which management expects to be a more normalized quarter as pricing actions take effect; cash flow from operations was SEK 310m, Q4 CapEx SEK 146m, FY2026 CapEx guided SEK 650–700m (≈SEK 100m remaining for Hungary), ROCE 14.2%, and sustainability progress includes a 96% reduction in Scope 1–2 and 30% reduction in upstream Scope 3 (base year 2021) with a science‑based Net‑Zero 2045 approval.
Q4 Sales Growth (Currency-Adjusted)
Net sales of SEK 2.272 billion in Q4, representing approximately 2% growth adjusted for currency headwinds (company-stated).
Full-Year Sales and Profitability Improvement
Full-year 2025 sales close to SEK 9.5 billion, +2% adjusted for currency. Operating profit increased 11% for the year and EBITA margin improved to 11.3% from 9.9% (increase of 1.4 percentage points).
Earnings Per Share and Dividend
Earnings per share of SEK 2.88 for 2025. Dividend proposal increased to SEK 1.70 per share from SEK 1.50, with a payout ratio of 59% (down from 61%).
Medical Solutions Growth and Scale
Medical Solutions delivered just above SEK 1.3 billion in Q4 sales, +5% adjusted for currency, and now represents 58% of group sales. Medical margin at 11.6% (up 0.4 percentage points vs 2024). Ongoing expansions in Hungary, Poland and Malaysia support global growth.
Engineered Solutions — Materials Performance
Engineered Solutions sales near SEK 1 billion in Q4 (42% of group sales). Materials subsegment grew ~10% adjusted for currency, and the Engineered business area margin improved to 9.9% from 9.2%.
Strong Cash Generation and Capital Discipline
Operating cash flow of SEK 310 million in the quarter. Q4 CapEx was SEK 146 million; full-year 2026 CapEx guidance set at SEK 650–700 million (around SEK 100 million remaining for the Hungarian project).
Return on Capital Employed
Return on capital employed (ROCE) improved to 14.2% for the full year 2025, indicating stronger capital efficiency.
Sustainability Milestones
Scope 1 & 2 emissions reduced by 96% vs base year (2021) — well ahead of the 70% 2030 target. Scope 3 upstream emissions reduced by 30% vs base year (vs 25% target). Net-zero 2045 target approved by SBTi.

Nolato AB (NLTBF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

NLTBF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 06, 2026
2026 (Q1)
0.08 / -
0.077
Feb 05, 2026
2025 (Q4)
0.08 / 0.06
0.066-6.67% (>-0.01)
Oct 28, 2025
2025 (Q3)
0.08 / 0.09
0.06731.15% (+0.02)
Jul 18, 2025
2025 (Q2)
0.08 / 0.09
0.0725.40% (+0.02)
May 06, 2025
2025 (Q1)
0.07 / 0.08
0.06616.67% (+0.01)
Feb 07, 2025
2024 (Q4)
0.07 / 0.07
0.032106.90% (+0.03)
Oct 25, 2024
2024 (Q3)
0.07 / 0.07
0.03974.29% (+0.03)
Jul 18, 2024
2024 (Q2)
0.07 / 0.07
0.0648.62% (<+0.01)
May 06, 2024
2024 (Q1)
0.05 / 0.07
0.05520.00% (+0.01)
Feb 06, 2024
2023 (Q4)
0.05 / 0.03
0.063-49.12% (-0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

NLTBF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 05, 2026
$6.65$6.650.00%
Oct 28, 2025
$6.60$6.72+1.89%
Jul 18, 2025
$6.09$6.42+5.41%
May 06, 2025
$5.39$5.84+8.40%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Nolato AB Class B (NLTBF) report earnings?
Nolato AB Class B (NLTBF) is schdueled to report earning on May 06, 2026, Before Open (Confirmed).
    What is Nolato AB Class B (NLTBF) earnings time?
    Nolato AB Class B (NLTBF) earnings time is at May 06, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is NLTBF EPS forecast?
          NLTBF EPS forecast for the fiscal quarter 2026 (Q1) is 0.08.